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Introduction 
Microsaccades are miniature fixational eye 
movements approximately 6 to 25-milliseconds 
in duration, through 1-120 arcminutes (up to 2 
full degrees of rotation), that occur at a rate of 
about 1-2 per second. Electrophysiological stud-
ies have demonstrated the role of the rostral pole 
of the superior colliculus in microsaccades in pri-
mate models (Hafed, Goffart & Krauzlis, 2009; 
Xue et al, 2017). For example, collicular neurons 
have been shown to be active for microsaccades 
in monkeys (Van Gisbergen, Robinson & Gielen 
1981), and Goffart, Hafed, & Krauzlis (2012) 
observed a significant drop in the microsaccade 
rate during fixation after deactivating the rostral 
deep SC of monkeys. Experimental inactivation 
of certain neurons in the monkey colliculus re-
duces the rate of microsaccades, but only if those 
neurons were implicated in movements of ≤5 de-
grees of arc (Hafed, Goffart, & Krauzlis, 2009). 
In humans, Attention Deficit Hyperactivity Dis-
order (ADHD) - a disorder that has been argued 
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to involve a dysfunction at the level of the supe-
rior colliculus (Overton, 2008)- is associated 
with alterations in the production of microsac-
cades (although this evidence is not entirely con-
sistent Fried et al., 2014; Panagiotidi, Overton & 
Stafford, 2017b, Mihali et al, 2018; Dankner et 
al, 2017; Roberts et al, 2017).  
Evidence suggests that collicular activity is 
modulated by a range of neurotransmitter sys-
tems, one of the least explored – at least in hu-
mans – is the adenosine system. Intraperitoneal 
administration of an adenosine deaminase inhib-
itor has been shown to enhance neural activity in 
the superficial grey layer of the superior collicu-
lus following electrical activation of the optic 
tract in the anaesthetised rat in vivo (Ishikawa, 
Saijoh, & Okada, 1997), as has the direct appli-
cation of adenosine to the superficial grey (Hirai 
& Okada, 1995). The superior colliculus ex-
presses both A1-type (Goodman and Snyder, 
1982) and A2-type adenosine receptor (Johans-
son & Fredholm, 1995), and the excitatory action 
of adenosine itself can be reproduced by the di-
rect application of selective A1-type and A2-
type adenosine receptor agonists (Hirai & 
Okada, 1995). In humans, adenosine action in 
the colliculus has been poorly researched, how-
ever, in the context of microsaccades, pilot work 
by Collins et al. (2009) suggests that caffeine in-
gestion results in fewer microsaccades, as might 
be expected following the removal of an excita-
tory influence in the colliculus. Caffeine acts at 
all four distinct adenosine receptors thus far 
identified, both in the rat and human brain, alt-
hough affinity data suggest that it’s actions are 
likely to be mainly mediated via and interaction 
with A1 and A2 receptors (Fredholm, Bättig, 
Holmén, Nehlig, & Zvartau, 1999), both of 
which are expressed in the colliculus (Goodman 
and Snyder, 1982; Johansson & Fredholm, 1995; 
Rosin, Robeva, Woodard, Guyenet, & Linden, 
1998). 
The present study follows on closely from the 
earlier pilot work by Collins et al. (2009) by ex-
ploring the effects of caffeine consumption on 
the production of microsaccades, this time in a 
full study, as an indirect assay of the potential 
excitatory action of adenosine in the human su-
perior colliculus. We recorded microsaccade rate 
during a simple sustained fixation task in a pop-
ulation of healthy adults, both before and after 
the consumption of caffeine. The primary hy-
pothesis was that there would be a decrease in 
microsaccade rate when measured after caffeine 
consumption compared to before. As well testing 
the effects of caffeine on microsaccade produc-
tion in a full study, we also had a more general 
aim of examining the utility of microsaccades as 
an assay of collicular function. Here, our inten-
tion was to scrutinize the stability of the measure 
in the absence and in the presence of a pharma-
cological manipulation. Demonstrating that mi-
crosaccades are stable over time pre-drug and 
stable over time (although their parameters may 
change) post-drug, would underscore their use-
fulness as an index of human collicular function 
and its modification. 
Methods 
Participants 
Twenty-seven participants (13 male) were re-
cruited via intra-university advertising at the 
University of Sheffield. The final group of 22 
participants (taking into account exclusions) had 
a mean age of 29.4 years ranging from 19-47 (SD 
= 8.57). Three participants were excluded from 
the final analysis as calibration problems pre-
Journal of Eye Movement Research 
12(6):12 
 
  3 
vented binocular tracking. Data for these partic-
ipants were collected monocularly, but ulti-
mately excluded from final analyses in order to 
standardise the data set. Two further participants 
were excluded due to strabismus that prevented 
successful calibration, leading to a total of five 
exclusions.  All subjects were right-handed, free 
from diagnosed neurological disorder or injury, 
and free from stimulant class medications (in-
cluding methylphenidate). Although none of the 
participants had a current diagnosis of ADHD, 
their relatively low levels of ADHD-like traits 
were confirmed by their low scores (mean 31.05; 
standard error 2.09) on the Adult ADHD Self-
Report Scale (ASRS; Kessler et al., 2005). 
Participants were asked not to ingest caffeine 
in the two hours before the study, both upon reg-
istration and in an email reminder of their study 
appointment the day before. They were told spe-
cifically to avoid caffeinated drinks such as cof-
fee and energy drinks, as well as caffeine tablets. 
All participants confirmed upon arrival, via the 
signing of the consent form, that they had not 
consumed any of the above examples of caffein-
ated beverages/tablets. 
Participants received £10 for taking part in the 
study. The subjects all gave their informed con-
sent to take part in the experiment and the proce-
dures were conducted in accordance with both 
the University of Sheffield’s ethics committee 
guidelines, and the Declaration of Helsinki.  
Eye tracking 
The eye tracking was performed using an 
Eyelink 1000 (SR Research Osgood, ON, Can-
ada), which recorded data binocularly at 500Hz. 
The fixation task was created from scratch using 
the experiment builder (SR Research Osgood, 
ON, Canada) software packaged with the Eye-
link hardware. The experiment was displayed to 
the participants on a 19" DMW LCD monitor 
with screen dimensions of 1024x768 and a 60hz 
refresh rate. The monitor was placed 65cm away 
from the participant headrest. The experiment 
took place inside an enclosed room with the cur-
tains drawn and light turned on in order to 
achieve a constant illumination level.  
Procedure 
A 9-point grid was used for calibration. Vali-
dation was deemed successful if the disparities 
from calibration were less than 1 degree. If vali-
dation was unsuccessful, calibration was re-
peated. The process took approximately 2 
minutes for each participant. Drift correction us-
ing a central fixation point was performed before 
every trial, to counter small inaccuracies in cali-
bration produced by pupil dilation and partici-
pant movements. Calibration was performed 
twice for each participant; at the beginning of 
each block.  
The task was administered after calibration 
and validation were complete. Following the in-
itial drift correction, a fixation cross appeared in 
the centre of the screen, which disappeared once 
the participant fixated upon it for 300ms. The re-
moval of the fixation cross triggered the appear-
ance of an orange target cross at one of 6 target 
positions with horizontal displacements of, re-
spectively, -8.6, -4.3, 0, 0, +4.3, +8.6 degrees, 
and vertical displacements of 0, 0, +6.4,-6.4,0,0 
degrees. Each target position was used 5 times in 
each block, with the order randomised to prevent 
predictive saccades. The participants were 
tasked with fixating upon the target cross for 5.5 
s until it disappeared. Research has suggested 
that fixations of 10 s or longer can to cause pupil 
contractions, which are significant confounding 
factors with regards to pupil centration and thus 
eye tracking calibration (Choe, Blake, & Lee, 
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2016). With that in mind, a presentation time 5.5 
s was considered to be a good compromise be-
tween the need to acquire sufficient data and 
avoiding the disruptive effects of pupil contrac-
tions. The removal of the target cross was fol-
lowed by 2.25 s of blank screen until the next 
trial began with a new drift correction calibration 
point.  
Each eye tracking session consisted of 2 
blocks of 30 trials. The removal of the black fix-
ation cross relied upon the participant fixating 
upon it successfully, which was of course reliant 
on both participant compliance and eye tracker 
accuracy. In the rare instances this was not 
achieved punctually, the eye tracker was recali-
brated. The eye tracking sessions took an aver-
age of approximately 12 minutes each, with a 
range of 10-15 minutes.  
Once the first eye tracking session was com-
plete, the participants were given tablets contain-
ing 300mg of caffeine to ingest with water. Caf-
feine was given in the form of one 200mg tablet 
(myvitamins.co.uk) and two 50mg tablets (Pro-
plus, Lane Health Products Ltd, Gloucester, UK) 
(for 300mg total) in which the only listed active 
ingredient was caffeine. This dosage was chosen 
as 300mg of caffeine has been shown to signifi-
cantly increase dopaminergic activity in the pu-
tamen and ventral striatum (Volkow et al., 2015), 
which means such a dose would likely serve our 
intended purpose of stimulating oculomotor cir-
cuitry. Further, moderate doses of caffeine (~300 
mg, 4mg/kg) have been shown to have behav-
ioural effects in various cognitive domains, in-
cluding attention, reaction times, and executive 
function (see McLellan, Caldwell, & Lieberman, 
2016, for review).  
 Participants had a 45-minute break between 
blocks, as caffeine bioavailability has been 
demonstrated to peak at 99% after approximately 
45 minutes (Liguori Hughes & Grass 1997). 
Upon the completion of this break period, the 
participants repeated the eye tracking session in 
exactly the same way as before. 
Data analysis 
Raw eye tracking data was preprocessed in 
Python using PyGaze (Dalmaijer et al, 2014). 
Microsaccade identification was performed us-
ing the Microsaccade Toolbox 0.9 (Engbert et al, 
2015). Unless otherwise specified the parameters 
used for identifying microsaccades were a mini-
mum duration of 6 samples (12 ms) and a veloc-
ity threshold scaling factor of 5. All raw data and 





Figure 1: Mean microsaccade count/second pre and 
post caffeine administration (lines connect 
measurements from the same individual pre and post). 
 
The mean count of microsaccades pre-
caffeine administration was 1.40 (sd 0.52), 
compared to a post-administration mean of 1.18 
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(sd 0.43). This was a statistically significant 
reduction (t(21) = 4.367, p = 0.00027) with a 
standardised effect size of 0.42 (Cohen’s d, a 
small to medium effect according to Cohen, 
1992). 
The pre-post correlation was 0.89 (Pearson’s 
r, p<0.0001). The stability of microsaccade 
count as an individual difference measure is 
visualised in Figure 1. 
There was no significant correlation between 
the ASRS score of ADHD traits and either pre-
administration microsaccade count or reduction 
in microsaccade count (r = 0.18, -0.13 
respectively, p = 0.43, 0.57). We note that 15 of 
our 22 participants had ASRS scores in the 




Figure 2: Surface plot of effect size (z-axis) against 
microsaccade identification parameters (minimum 
duration, ‘mindur’, x-axis, and velocity threshold 
scaling factor, ‘vfac’, y-axis). For full description of 
these parameters see Engbert et al. 2015 
 
The prior analysis used standardised 
parameters for microsaccade identification (see 
method). We confirm that the apparent 
sensitivity of microsaccade count to caffeine 
administration is not due to the specific 
parameters picked to identify microsaccades by 
recalculating the pre and post caffeine 
microsaccade counts from the raw data with 
values of the minimum duration parameter 
between 2 and 11 samples (6 was our default) 
and velocity threshold scaling factor between 3 
and 8 (5 was our default). The results are shown 
in Figure 2, confirming that the pre-post 
difference is not an artifact of choice of 
microsaccade identification parameters. 
 
 
Figure 3: Sensitivity analysis, showing mean (line) and 
bootstrapped 95% confidence range (shaded area) for 
the effect size of pre-post caffeine microsaccade count 
difference for analysis based on 3 – 60 trials. 
 
Note that effect size is well above zero for all 
combinations of identification parameters, ex-
cept for the most conservative. 
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Figure 4: Sensitivity analysis, showing mean (line) and 
bootstrapped 95% confidence range (shaded area) for the 
pre-post caffeine microsaccade count correlation for anal-
ysis based on 3 – 60 trials. 
 
It is also possible to use the collected data to 
ask how stable the obtained results would be if 
less data had been collected from participants. 
Our standard analysis uses data from all 60 trials, 
but we are interested in how stable the results 
would have been if we had collected fewer trials. 
Using bootstrap resampling, we calculate 95% 
confidence ranges for the two summary statistics 
– pre-post correlation of microsaccade count 
within subjects, and effect size of pre-post 
microsaccade count difference. The results are 
shown in Figure 3 and Figure 4. 
 
Figure 5 shows average microsaccade count 
for each trial, both pre and post caffeine 
administration. Although later trials, both pre 
and post, are associated with a higher 
microsaccade count, the main effect of a lower 
count post-caffeine is also clearly visible. 
 
 
Figure 5: Average microsaccade count against trial 
number, pre and post caffeine administration. 
Discussion 
As predicted, caffeine administration reduced 
microsaccade count, on average. Additional 
analysis of the results suggests that microsaccade 
count has promise as an individual difference 
measure. There was a high consistency of mi-
crosaccade count across our testing sessions, as 
is desirable for a trait measure. The mean differ-
ence pre/post caffeine administration suggests 
that microsaccade count is sensitive to caffeine, 
as predicted by earlier work (Collins et al, 2009) 
and by analysis of the circuitry involved in sac-
cade generation (Overton, 2008). We have 
shown that this difference is robust to choice of 
parameters used to identify saccades. This sug-
gests that microsaccade count may also be suita-
ble as a state measure.  
The sensitivity analysis suggests that both the 
individual stability of microsaccade count and 
the sensitivity of caffeine (as reflected by the be-
tween session difference) could be reliably de-
tected with approximately half the number of tri-
als we used. 
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Microsaccades can be measured with low par-
ticipant effort, and are suitable as a repeated 
measure (i.e. have negligible learning or fatigue 
effects).  
Our interest in microsaccades originated be-
cause we hoped they would provide a good index 
of collicular function. This is not directly tested 
by the present work, which is focused on the sen-
sitivity and stability microsaccade count as a 
measure. Nonetheless, the present results sup-
port the potential of microsaccade count for fur-
ther investigation as a possible biomarker of drug 
response, possibly at the collicular level. If mi-
crosaccade rate reflects collicular activity levels 
the measure may provide a means of initially 
screening potential pharmacotherapies for disor-
ders with a collicular component. Attention Def-
icit Hyperactivity Disorder may be one such con-
dition, and in that regard it is interesting that 
adults presenting with ADHD report regular and 
increased consumption of caffeine through a va-
riety of beverages over time (Magon and Müller, 
2012), and adolescents with a diagnosis of 
ADHD are nearly as twice likely to consume caf-
feine than are adolescents without ADHD 
(Walker, Abraham & Tercyak, 2010). 
Circumstantial support for the idea that 
ADHD may involve collicular hyperactivity in-
clude that those higher in ADHD-like traits 
demonstrate heightened sensitivity to peripheral 
cues (Panagiotidi, Overton & Stafford, 2017a), 
have an altered temporal integration window for 
multisensory stimuli (Panagiotidi, Overton & 
Stafford, 2017c), and report higher levels of sen-
sory sensitivity and processing problems (Panag-
iotidi, Overton & Stafford, 2018). 
Limitations of the present research which can 
be addressed in future work include assessing the 
stability of microsaccade count over longer time 
periods, and directly comparing caffeine admin-
istration with placebo.  Factors such as fatigue, 
attention and arousal have a known influence on 
microsaccade rate (Di Stasi et al, 2013), and so 
could plausibly be involved in producing the ob-
served pre- and post- caffeine administration dif-
ferences. Ultimately any strong causal inference 
about the effect of caffeine on microsaccade rate 
must wait for direct confirmation with an exper-
iment with a non-drug control condition. It 
would also be worthwhile to investigate if mi-
crosaccade count can be reliably assessed during 
active viewing (i.e. without using fixation trials, 
which can be monotonous for participants). 
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